<?xml version="1.0" encoding="UTF-8"?>
<p>The combination of MMF and highly active antiretroviral therapy improved the control of viral replication and delayed viral-load rebound in a randomized pilot study (
 <italic>n</italic> = 17).
 <sup>
  <xref rid="bibr26-1759720X20947296" ref-type="bibr">26</xref>
 </sup>
 <italic>In vitro</italic> and 
 <italic>in vivo</italic> studies showed cytostatic and antiviral effect by depletion of the dividing CD4+ T cells.
 <sup>
  <xref rid="bibr93-1759720X20947296" ref-type="bibr">93</xref>
 </sup>
</p>
